<DOC>
	<DOCNO>NCT01834105</DOCNO>
	<brief_summary>This study use RT-PCR Western Blot technique detect expression CLCF1 mRNA protein POP Kidney Yin deficiency group healthy group verify relevance CLCF1 POP kidney Yin deficiency syndrome.Through siRNA overexpression , observe mRNA protein 's expression CBP、JAK1、STAT4 protein phosphorylation JAK1、STAT4 JAK-STAT signal reveal CLCF1 regulate CBP 's mechanism.Use Liuwei Dihuang Pills detect effect treatment , compare use Liuwei Dihuang Pills detect mRNA protein 's expression CLCF1、CBP etc.Aim clarify POP kidney Yin deficiency molecular mechanism .</brief_summary>
	<brief_title>Molecular Mechanism POP Kidney Yin Deficiency Syndrome From Interventional Effects CLCF1</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Yin Deficiency</mesh_term>
	<criteria>The Participants volunteer test subject , accept experimental drug , promise finish course sign informed consent . Female age 45 75 go natural menopause two year In accordance western medicine diagnostic criterion osteoporosis belong kidney Yin deficiency syndrome differentiation traditional Chinese medicine certificate ; In accordance western medicine diagnostic criterion ; In accordance TCM diagnostic method ; .If answer , The subject could n't study . Do accord standard western medicine diagnosis TCM diagnostic method Age : &lt; 44 &gt; 76 year old ; With hyperparathyroidism , osteomalacia , rheumatoid arthritis , multiple myeloma serious complication secondary osteoporosis ; Late deformity , disability , loss labor ; With cardiovascular , cerebrovascular , liver , kidney hematopoietic system serious primary disease ; Psychosis alzheimer 's patient ; Nearly three month , use hormone replacement therapy ( HRT ) take calcitonin , nearly six month use double phosphonic acid salt 15 day , etc . ; This medicine allergic constitution composition know allergy ; In critical condition , It 's difficult make exact evaluator efficacy safety new drug ;</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Postmenopausal osteoporosis ; Kidney Yin deficiency syndrome ; Liuwei dihuang pill ; CLCF1 ; JAK - STAT signal pathway</keyword>
</DOC>